Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Biogen (BIIB) Earnings Date, Estimates & Call Transcripts

Biogen logo
$250.34 -3.50 (-1.38%)
As of 02:03 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Biogen Earnings Summary

Biogen announced Q2 2026 earnings on July 29, 2026, reporting an EPS of $3.60, which topped analysts' consensus estimates of $2.94 by $0.66. Quarterly revenue rose 3.4% year-over-year to $2.74 billion, above the consensus estimate of $2.46 billion. With a trailing EPS of $5.65 and a P/E Ratio of 44.31, Biogen's earnings are expected to grow 29.24% next year, from $12.31 to $15.91 per share.

Upcoming Q3
Earnings Date
Oct. 28Before Market OpensEstimated
Consensus EPS
(Jul. 29)
$2.94
Actual EPS
(Jul. 29)
$3.60 Beat By $0.66
Actual Revenue
(Jul. 29)
$2.74B

Q2 2026 Earnings Resources

BIIB Upcoming Earnings

Biogen's Q3 2026 earnings is estimated for Wednesday, October 28, 2026, based on past reporting schedules, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Biogen Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biogen and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

BIIB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIIB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Biogen Upcoming Earnings Consensus

Report Date
October 28, 2026
Consensus EPS Estimate
$1.97
Consensus Revenue Estimate
$2.64B

Biogen Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS GuidanceRevenue Estimate at Guidance
Q1 20267$1.45$4.60$3.20
Q2 20267$2.90$4.57$3.76
Q3 20267$3.07$4.42$3.91
Q4 20267$3.33$4.53$3.74
FY 202628$10.75$18.12$14.61
Q1 20273$3.31$4.37$3.94
Q2 20273$4.00$4.95$4.54
Q3 20272$4.18$4.34$4.26

Biogen Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/28/2026
(Estimated)
-$1.97---$2.64B-
7/29/2026Q2 2026$2.94$3.60+$0.66$0.66$2.46B$2.74B
4/29/2026Q1 2026$2.95$3.57+$0.62$2.15$2.29B$2.48B
2/6/2026Q4 2025$1.61$1.99+$0.38-$0.33$2.21B$2.28B
10/30/2025Q3 2025$3.89$4.81+$0.92$3.17$2.34B$2.53B
7/31/2025Q2 2025$3.93$5.47+$1.54$4.33$2.32B$2.65B
5/1/2025Q1 2025$3.26$3.02 -$0.24$1.64$2.25B$2.43B
2/12/2025Q4 2024$3.43$3.44+$0.01$1.83$2.42B$2.45B
10/30/2024Q3 2024$3.77$4.08+$0.31$5.50$2.43B$2.47B

Biogen Earnings - Frequently Asked Questions

Biogen has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 28th, 2026 based off last year's report dates. Learn more on BIIB's earnings history.

Biogen updated its FY 2026 earnings guidance on Wednesday, July, 29th. The company provided earnings per share guidance of 12.000-13.000 for the period, compared to the consensus earnings per share estimate of 13.450. The company issued revenue guidance of -, compared to the consensus revenue estimate of $10.1 billion.

In the previous quarter, Biogen (NASDAQ:BIIB) reported $3.60 earnings per share (EPS) to beat the analysts' consensus estimate of $2.94 by $0.66. Learn more on analysts' earnings estimate vs. BIIB's actual earnings.

The conference call for Biogen's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Biogen's latest earnings report can be read online.
Read Transcript

Biogen (NASDAQ:BIIB) has a recorded annual revenue of $9.89 billion.

Biogen (NASDAQ:BIIB) has a recorded net income of $1.29 billion. BIIB has generated $5.65 earnings per share over the last four quarters.

Biogen (NASDAQ:BIIB) has a trailing price-to-earnings ratio of 44.93 and a forward price-to-earnings ratio of 20.62. The price/earnings-to-growth ratio is 2.68.

Biogen's earnings are expected to grow from $12.31 per share to $15.91 per share in the next year, which is a 29.24% increase.


Earnings data for NASDAQ:BIIB is sourced from Fiscal.ai, with the most recent quarter reported on 7/29/2026. New results are added as companies report their earnings.
From Our Partners